Introduction
Tobacco use during the perinatal period is associated with significant and costly morbidity and mortality for both mother and infant. In addition to poor birth outcomes associated with tobacco use (Hammoud et al. 2005; Herrmann et al. 2008; Salihu and Wilson 2007; U. 
S. Department of Health and Human Services 2004), continued tobacco
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While pregnant women are recognized as an important group to target for smoking cessation interventions, abstinence remains a challenge prior to and following delivery. Efficacious interventions for pregnant women exist (Chamberlain et al. 2013; Fiore et al. 2008; Hartmann-Boyce et al. 2014; Lumley et al. 2009 ), yet many do not receive tobacco cessation treatments during and/or after their pregnancy (Dempsey et al. 2015; Tran et al. 2010) . Though tobacco screening in prenatal care is generally high, additional cessation support or interventions for smoking are not being reliably administered (Bailey and Jones Cole 2009; Jordan et al. 2006) . Previous studies have recommended incorporating interventions into routine clinical care (Fang et al. 2004; Secker-Walker et al. 1995) to promote cessation, but most health care settings have struggled to make this a reality.
In 2012, the Joint Commission implemented tobacco performance measures to address tobacco screening and treatment as part of medical care (The Joint Commission 2011). Integrating tobacco cessation into standard clinical practice through "opt-out" assessment and referral programs is one way to ensure that these services are built into the provision of care for perinatal smokers. In opt-out programs, all patients receive services as part of routine standard of care unless they indicate refusal of services. Opt-out tobacco cessation work conducted with pregnant smokers has been done in the United Kingdom (UK) and has found that, (1) women were accepting of an optout system to obtain cessation support , (2) in a pre-post evaluation of an opt-out system, results showed improved rates of setting quit dates and reported cessation among smokers identified by biochemical verification , and (3) staff were generally supportive of opt-out tobacco systems in antenatal clinics . These findings, while promising, may not apply in the United States (US) given differences in medical systems and support for perinatal women. Thus, studies evaluating opt-out tobacco cessation programs for pregnant women in the US are needed.
Within a major academic medical center in the southeastern US, a comprehensive opt-out tobacco treatment service for inpatients was launched in February 2014. Through this clinical program, all admitted patients are screened for tobacco use and current tobacco users are referred automatically for cessation support while in the hospital and enrolled in a follow-up phone-based system (Nahhas et al. 2016) . Data collected from this service presents a unique opportunity to investigate the reach and impact of this program amongst a population of perinatal smokers. This paper describes the prevalence and characteristics of tobacco use among perinatal patients, the overall reach rates of the opt-out tobacco cessation program, and self-reported smoking cessation outcomes assessed within 30 days post-discharge.
Methods
This opt-out program was implemented within a major academic medical center in the southeastern US (Medical University of South Carolina health system, Charleston SC, USA). This hospital is the only tertiary/quaternary care referral center in the state (4.8 million people) and is located in a mid-sized metropolitan area. The opt-out tobacco treatment inpatient service involves three steps; (1) screening: all patients are asked about tobacco use at admission and all tobacco users are automatically referred to a tobacco treatment specialist (TTS) through the electronic medical record (EMR), (2) referral/Inpatient Counseling: the TTS conducts bedside cessation counseling (involves psychosocial education, motivational enhancement, skillsbased training, and relapse prevention) when possible based on patient availability and the caseload for that day and recommends treatment options to be acted upon by the medical care team, and (3) follow-up: all tobacco users are automatically enrolled in an interactive voice response (IVR) system, which prospectively follows up with patients for 30 days after discharge. This system has been described in further detail elsewhere (Nahhas et al. 2016) .
Inpatient records were examined from February 2014 until March 2016 for women (18 years or older) admitted to the labor and delivery and/or postpartum care units. To ensure appropriate selection of the target sample the following inclusion/exclusion criteria were implemented. First, patients with multiple admissions were only counted once. Second, in rare instances, patients were admitted to labor/delivery units that were beyond typical child-bearing age (most likely due to bed unavailability on other units). Any admission where the patient was over 41 years of age was inspected and excluded if not pregnancy-related. This research was conducted in accord with prevailing ethical principles and was approved by the Institutional Review Board at the author's institution.
The following data elements were collected: age, race, ethnicity, primary language, insurance status, length of hospital stay, and smoking status (current, former, or never smoker). Demographics were back-filled from the EMR and were not consistently available for all records. The following measures were collected as part of bedside counseling with the TTS; smoking status, frequency, history, quit attempts, motivation to quit, confidence and readiness to quit, and pharmacotherapy recommendations (from the TTS). The IVR post-discharge system contacted enrolled patients at 3, 14, and 30 days post-discharge. Information was collected on smoking status, frequency, quit attempts, motivation to quit, use of nicotine replacement therapy (NRT) and whether the patient wanted to be transferred to the quitline.
Frequency and proportions of patient demographics and smoking characteristics were reported for categorical variables while means and standard deviations were reported for continuously-measured variables. Statistical analyses were conducted on the following outcome measures obtained via the IVR system; reach rate of the IRV system (reached at least once during the 30-day post-charge period), smoking abstinence (yes/no based on the last known status reported during a follow-up call or considered smoking if patient was not reached), use of NRT (yes/no), and transfer to the quitline (yes/no). Risk ratios (RR) and 95% confidence intervals (CI) were calculated for all follow-up outcome measures. An intent-to-treat analysis was applied to the abstinence outcome such that patients who were not reached at follow-up were considered to be smoking, allowing for a conservative estimate of quitting. Outcome measures were compared between those who received bedside counselling and IVR versus those who received IVR only. Given low rates of NRT use and quitline transfer, statistical outcomes should be interpreted cautiously. All statistical analyses were done in SAS 9.4 (Cary, NC).
Results
Patient distributions within the opt-out system are shown in Fig. 1 . Among the 5649 women screened at the time of admission to the perinatal units, 10% (n = 553) reported current use of tobacco and 16% (n = 898) reported being former smokers. Over half of current smokers identified through the EMR were visited by a TTS (56%; n = 312). Among eligible patients, 64% (198/312) accepted the bedside consult. A total of 12 patients who were visited denied smoking in the past 30 days. The remainder of the patients were either not available at the time of consult (n = 77) or refused (opted-out) of the bedside consult (n = 25). Just under half of current smokers (44%; n = 241) were discharged from the hospital before the consult could be arranged. A total of 421 women were deemed eligible to receive follow-up calls after discharge. Reasons for ineligibility for follow-up calls included; not providing a phone number, not having a valid phone number, or being discharged to a location other than home.
Available demographic data are shown in Table 1 . The average age of perinatal inpatients included in this analysis was 29 years and the average duration of hospitalization was 3 days. Approximately 40% of the admitted women were African American, 43% Caucasian, and 2% Hispanic/Latino. The majority of women (89%) reported English as their primary language and the most common form of insurance was Medicaid (49%).
Among the 198 women who accepted the bedside consult, the average years of smoking was 12 and average number of cigarettes smoked per day was 11 (Table 2) . Ninety-two percent (n = 145) reported being daily smokers before hospital admission, 84% (n = 122) reported smoking within 5 min of waking, and 75% (n = 136) reported living with another smoker. Only 10% (n = 19) reported making a quit attempt in the past year. Despite the low rate of reported quit attempts, 37% (n = 70) of women reported moderate to high intention to quit after discharge and 20% (n = 38) reported moderate to high confidence to quit. Despite their high nicotine dependence, less than half (43%; n = 72) of the women reported strong cigarette cravings since admission. Of those reporting cravings, 81.2% (n = 56) expressed interested in nicotine replacement therapy.
Of the women who were visited by a TTS and eligible for follow-up (n = 187), 65 were reached by phone at least one time within a month after discharge. Among those who did not receive a bedside consult while hospitalized and eligible for follow-up (n = 234), 83 were reached by phone. Of those, 33 denied being smokers at the time of hospital admission and were excluded from the follow-up system and analyses. Comparisons between the bedside counseling and IVR group versus the IVR only group are shown in Table 3 . Using an intent-totreat (ITT) method, abstinence was higher (RR 1.98, 95% CI; 1.04-3.78) among those who received a bedside consult. Among those reached by phone and included in analyses (n = 115), NRT use was low and no differences were found between women who received a bedside consult compared to those who had not received a consult (10/65 in the bedside counseling and IVR group and 2/50 in the IVR only group). Among those same patients, 14 requested a transfer to the quitline (7/65 in the bedside counseling and IVR and 7/50 in the IVR only group). This comparison also did not reach statistical significance.
Discussion
This real-world, hospital-based, opt-out tobacco assessment and cessation program was able to reach 198 perinatal smokers during their inpatient stay and another 83 patients not seen at the bedside by phone after discharge, yielding an overall reach rate of 67% (281/421). Of the women screened for tobacco use, 10% were current smokers. This is consistent with prevalence figures reported in the literature (Curtin and Matthews 2016; Dietz et al. 2010; Tong et al. 2013) . Overall receptivity to the bedside consult was high; only 8% of women visited by the TTS opted-out of the consult. Among women who were counselled at the bedside, 37% reported a moderate to strong intention to quit smoking after discharge, but many lacked confidence in their ability to quit. This suggests that women are motivated to quit smoking after delivery; however, more should be done to support their quitting efforts after discharge in an effort to reduce environmental smoke exposure in newborns and prevent the detrimental effects of prenatal smoking in future pregnancies.
Follow-up data indicate that women who received bedside counseling during their inpatient stay exhibited greater abstinence compared to women who were not seen by a TTS, though most women had returned to smoking within 1 month after discharge (90% based on an ITT analysis). While the response to follow-up calls was only 35%, the women referred to this service represent a difficult-to-treat population and some may not have ever contacted tobacco cessation resources during their prenatal care. Even modest program reach rates could have a significant impact on public health and cost savings within the hospital system for both mother and infant. Given the volume of admissions, the brief hospital stay for most women, and the chaotic nature of the inpatient stay (i.e., visitors, childcare, consults, etc.); the rate of counselor contact with current smokers is impressive. The inpatient stay represents a critical moment that should be capitalized on to deliver cessation services, provide resources including pharmacotherapy, and potentially engage partners and family members in tobacco cessation as well. Additionally, this automatic referral system does not place added burden on healthcare staff, who are already balancing high caseloads and competing demands on their time.
While this opt-out tobacco cessation service reached an important patient population, there are several areas of need that are illuminated from the current analysis. First, women who report being former smokers at admission are not referred to this program. It is likely that many of these women quit smoking during pregnancy and are at risk of relapsing during the postpartum period. Among the 15-60% of smokers who quit during pregnancy (Ershoff et al. 2000; Morasco et al. 2006) , the majority of these women (50-70%) resumed smoking 2-3 months postpartum (Johnson et al. 2000; Kahn et al. 2002; Mullen et al. 1997; O'Campo et al. 1992; Severson et al. 1997 ). While former smokers should be included in this program, that would require additional staff time and resources, which remains a considerable challenge.
Second, smoking is likely under-reported among perinatal patients at the time of admission. Biochemical testing for nicotine has shown that smoking rates for pregnant women are potentially underestimated by up to 25% (Shipton et al. 2009 ). In the current sample, 8% (45/553) of women seen either at the bedside or reached by phone claimed that the medical records had misclassified them as current smokers. While some misclassification is possible, it is also possible that these women were underreporting their tobacco use. To combat potential underreporting, the implementation of biochemical verification to identify smokers and enroll them in opt-out cessation services may be necessary to expand reach. In the UK, studies have found that routine biochemical verification of smoking has been met favorably Sloan et al. 2016) , suggesting that it could be an acceptable routine practice in the US.
Third, reach rates during the inpatient stay and through follow-up calls could be improved. Special attention should be paid to those who opt-out of services or do not answer follow-up phone calls. One study examining the predictors of opting-out of this program for the general inpatient population demonstrated that being male, being younger, having Medicaid or no insurance, and not having received a bedside consult was associated with either opting-out of counseling or failure to make contact post-discharge through the follow-up system (Nahhas et al. 2016) . This study has several limitations. First, this is an evaluation of a clinical tobacco cessation hospital service, and as such, data were not collected necessarily for research purposes, bedside consults and interviews were not standardized, and there was missing data from the EMR. Second, post-discharge abstinence outcomes are self-reported and no biochemical confirmation of abstinence was collected. Third, given missing demographic information, it cannot be ensured that the analyzed sample was representative of the perinatal population of the hospital generally. However, this clinical service is applied to all inpatients, without any selection criteria, and therefore we have no reason to expect Table 2 Tobacco characteristics of patients interviewed and counselled by a bedside tobacco treatment specialist during their inpatient stay (n = 198) Note the varying numbers of records that contribute to the data of the individual interview items. Percentages represent responses among patients who were asked that particular question that our sample would be biased or fail to represent the patient population. Despite high quit rates during pregnancy, 8-12% of women continue to smoke during pregnancy and following delivery, highlighting a critical need to address smoking late in gestation or at delivery while reducing burden, time, training requirements, and cost. The opt-out tobacco screening and cessation program described here reached a highly nicotine-dependent perinatal population, many of whom were receptive to the service, and it appeared to improve abstinence rates post-discharge. To our knowledge, this is first demonstration of an opt-out inpatient tobacco cessation program among perinatal women in the US. This system is contributing to the goal of changing the default system of tobacco treatment (Richter and Ellerbeck 2015) , which currently requires patients to actively seek out and engage in tobacco cessation. However, results are preliminary, and additional program features of higher intensity may be required. Moving forward, future research should address how to improve the reach and impact of interventions designed for women late in gestation or after delivery. Inpatient stays might be the first time that women are offered cessation resources and this opportunity should be taken among this population. Opt-out tobacco cessation services are a potentially pragmatic solution to promote abstinence that may have a significant impact on the health outcomes of a perinatal population and their children. 
